Xcelerate Issues Year-End Update on Strategic Focus and 2026 Plans

Core Insights - Xcelerate, Inc. has made significant strategic adjustments in 2025 to align resources with long-term objectives, including the sale of its interest in ESN Group to strengthen its financial position and refocus on core missions [2][3] Financial Developments - The sale of ESN Group was an all-cash transaction that allowed Xcelerate to eliminate merchant finance debt associated with ESN, thereby improving its balance sheet [2] - The proceeds from the ESN sale, along with funds raised in a private placement, position the company to implement its AI-assisted patient portal program in early 2026 [3] Strategic Initiatives - Xcelerate is renewing its focus on AfiyaSasa Africa, LLC, aiming to launch an AI-assisted patient portal in Tanzania, which will connect patients in remote areas to clinicians [3][4] - The company is advancing its medical device patents, including a Surgical Tool with Targeting Guidance, and has filed additional applications in the EU and China [4] Communication and Engagement - To enhance transparency and shareholder engagement, Xcelerate is updating its corporate website and increasing its social media presence to share insights and progress updates [5] - A dedicated Investor Relations email will be established to streamline communication with shareholders [5] Future Outlook - In 2026, Xcelerate plans to carefully advance its key initiatives, particularly the AfiyaSasa platform, with a focus on testing technology in clinical settings and refining operations [6] - The company aims to maintain regular updates and transparent communication with shareholders as it progresses with AI-driven healthcare solutions [6]